Namenda (Memantine) — Patient Guide (UK)

Namenda is a medicine containing memantine. It is used to treat moderate to severe Alzheimer’s disease. This guide explains what Namenda is, how it works, how it is usually taken, and what to consider for safe use in the United Kingdom.

Note: Always follow the instructions given by your healthcare professional and read the patient information leaflet provided with your medicine.

Key product information

What is memantine, and what is Namenda used for?

Namenda (memantine) belongs to a group of medicines known as NMDA receptor antagonists. It is used in people with Alzheimer’s disease—specifically for moderate to severe Alzheimer’s dementia.

In practice, Namenda may help with:

• Thinking and memory function
• Everyday activities (for example, maintaining routine tasks)
• Behavioural symptoms that can occur in later stages

It’s important to understand expectations: Namenda is designed to help manage symptoms and may slow deterioration in some people, but it does not cure Alzheimer’s disease.

How Namenda works (mechanism of action)

Brain cells use chemical signals called neurotransmitters. One of these is glutamate. In Alzheimer’s disease, excessive glutamate signalling may contribute to cell damage over time.

Memantine helps by blocking NMDA receptors (a type of glutamate receptor) in a way that is thought to reduce harmful overstimulation while still allowing necessary signalling.

This action may help protect brain function and reduce symptom progression in moderate to severe stages.

Pharmacokinetics (how your body processes memantine)

Understanding pharmacokinetics can help explain dosing schedules and interactions.

• Absorption: Memantine is absorbed after taking by mouth.
• Distribution: It spreads through body tissues, including the brain.
• Metabolism: A large portion is not extensively metabolised and is handled largely by the body’s natural elimination routes.
• Elimination: Memantine is mainly cleared through the kidneys.
• Half-life: The medicine has a relatively long half-life, supporting once or twice daily dosing depending on the formulation and prescriber plan.

Kidney function matters: Because memantine is eliminated by the kidneys, people with reduced kidney function may require dose adjustments or closer monitoring.

Indications (when Namenda is used)

Namenda is indicated for:

• Moderate to severe Alzheimer’s dementia

For some people, memantine may be used alongside other Alzheimer’s medicines, such as those that affect acetylcholine. Whether combination treatment is appropriate depends on your medical history, symptoms, and tolerability.

Typical dosing and timing

Dosing is individualised. However, the general approach for many people is a gradual titration to reduce side effects.

Starting and increasing dose

Memantine is commonly introduced in a stepwise manner, with the dose increased over several weeks until a target maintenance dose is reached. The exact schedule can vary by product strength and local prescribing practices.

How often to take it

• Once daily schedules are used with certain formulations.
• Twice daily schedules may be used depending on the tablet strength and local regimen.

Try to take it around the same time each day to maintain steady levels.

What to do if you miss a dose

• If you remember soon after, take it if it’s still close to your usual time.
• If it’s near the time for the next dose, skip the missed dose and continue as normal.
• Do not take a double dose to make up for a missed one.

Food interactions

Memantine can generally be taken with or without food. Many people find that taking it with a meal helps reduce stomach discomfort or nausea.

Practical tip: If you experience dizziness, tiredness, or nausea when you first take your dose, consider taking it after food and at a time of day when you can rest if needed.

Alcohol interactions

Alcohol can affect memory, balance, sleep quality, and judgment—areas that may already be impacted by Alzheimer’s disease.

• It may increase side effects such as dizziness or drowsiness.
• Alcohol could also worsen confusion or reduce consistency with daily routines.

Advice: It is best to limit alcohol and discuss your specific situation with your healthcare team, particularly if you or your caregiver notice worsening confusion, falls, or sleep disturbances.

Interactions with other medicines

Memantine can interact with medicines that affect the urinary system (because it is cleared by the kidneys) or that influence the nervous system. Always check with a healthcare professional or pharmacist before combining medicines.

Common categories of interactions

• Medicines that change urine acidity (pH of urine), such as some used for urinary problems or conditions affecting metabolism. These may alter how quickly memantine is cleared.
• Other NMDA-related medicines, including certain medicines used in anaesthesia or for cough (depending on active ingredients). Combining may affect tolerability.
• Amantadine and similar medicines (used for other conditions) may have additive effects.
• Cimetidine (commonly used for stomach acid-related conditions) may affect clearance in some circumstances.
• Other drugs affecting mental status (for example, sedatives). These combinations can increase confusion, drowsiness, or falls risk.

Non-prescription medicines and supplements

Even over-the-counter products can interact. Include:

• cough/cold remedies
• sleep aids
• antacids and stomach acid treatments
• herbal products

Tip: Keep a list of your medicines (including doses) and show it to your pharmacist when you request Namenda or any related products.

Safety profile and side effects

Like all medicines, Namenda can cause side effects. Many people experience mild or temporary effects, and side effects often improve after dose adjustments.

Seek medical advice urgently if

• you develop signs of an allergic reaction (e.g., rash, swelling of face/lips, difficulty breathing)
• you have severe confusion that is new or rapidly worsening
• you experience fainting, severe dizziness, or repeated falls

Common side effects

These may occur, particularly during the first weeks:

• Dizziness
• Headache
• Constipation
• Tiredness or sleepiness
• Confusion or increased agitation in some people

Less common but important effects

• Changes in walking balance
• Shortness of breath or chest discomfort (seek advice)
• Infections (people with dementia may be more vulnerable overall)

Who needs extra caution?

• People with reduced kidney function (dose may need adjustment)
• Those at higher risk of falls or with existing balance problems
• People taking multiple medicines that affect the nervous system

Practical use tips for patients and carers

Namenda is often used long-term. Following a few practical strategies can improve safety and make daily use easier.

Make taking it easier

• Use a blister pack or a daily pill organiser.
• Link it to a routine (e.g., breakfast or evening tea).
• If the person you care for forgets doses, consider a carer-administered checklist.

Monitor effects in a helpful way

• Note any changes in sleepiness, dizziness, constipation, or agitation.
• If side effects occur, discuss them promptly—dose adjustment or slower titration may help.
• Keep track of bowel movements and increase fluid/fibre where appropriate, as constipation can worsen comfort.

Falls prevention

• Be careful with night-time mobility.
• Ensure good lighting and remove trip hazards.
• Stand up slowly and review other medications that may increase dizziness.

Stopping the medicine

Do not stop Namenda suddenly without medical advice. If discontinuation is planned, a clinician will guide you on how to do it safely.

Alternative options

Depending on stage of symptoms, tolerability, and individual medical history, alternatives may include:

• Other Alzheimer’s medicines (for example, cholinesterase inhibitors). These target different pathways in the brain.
• Combination therapy in some cases (memantine plus another Alzheimer’s medicine).
• Non-drug approaches that support quality of life, such as structured routines, cognitive stimulation activities, physiotherapy for mobility, and caregiver support.

The “best” option depends on symptom pattern, progression rate, side effect profile, comorbidities, and kidney function. A clinician can help tailor the plan.

Market and legal context in the UK

In the United Kingdom, medicine availability, prescribing rules, and supply processes are regulated. Namenda (memantine) is an established treatment for Alzheimer’s disease and is supplied through standard medicine distribution channels. Pharmacies in the UK operate under medicines regulations that aim to ensure safe supply, correct labelling, and appropriate patient counselling.

Patients may also encounter:

• Brand and generic versions of memantine (availability depends on manufacturers and local supply).
• Different strengths and presentations, which can affect how doses are taken and titrated.

Always check that the product you receive matches the strength and formulation agreed in your treatment plan.

Recent guidance (UK context)

Clinical practice in the UK continues to emphasise evidence-based management of Alzheimer’s disease, typically including:

• Regular review of symptoms and function
• Monitoring for side effects and interactions
• Assessing kidney function where relevant
• Considering support for carers and non-drug strategies alongside medication

Guidance can be updated over time. Your healthcare professional can confirm the most current approach for your situation, including whether memantine is appropriate and how to monitor benefit.

Delivery and availability (what to expect)

Online pharmacy availability may vary based on:

• strength and formulation (e.g., tablets of different strengths)
• current stock levels
• seasonal supply and manufacturer availability

When ordering medicines online in the UK, reputable pharmacies typically provide:

• Clear product identification (strength, form, and active ingredient)
• Tracking for delivery where available
• packaging designed to maintain product integrity
• Customer support if you have questions about your order

Tip: If you’re using memantine as part of a long-term routine, consider ordering enough in advance to avoid gaps—especially if you live far from delivery hubs or during public holidays.

FAQ — Namenda (Memantine)

1) How long does Namenda take to work?

People vary. Some may notice changes gradually over weeks to months. If no benefit is seen, it doesn’t necessarily mean memantine is unsafe—it may mean your doctor needs to review the overall treatment plan. Regular follow-up helps assess whether continuing is worthwhile.

2) Can I take Namenda in the morning or evening?

Yes—many people take it once daily or split doses depending on the formulation. Choose a time that fits your routine. If side effects like dizziness or tiredness occur, consider taking it at a time when you can rest and discuss options with your pharmacist or clinician.

3) What if the person I’m caring for becomes more confused after starting?

Confusion can have many causes (infection, dehydration, constipation, medication changes). Contact a healthcare professional promptly if confusion worsens after starting memantine, particularly if it is sudden or severe.

4) Does food affect Namenda?

Memantine can generally be taken with or without food. Taking it with meals may reduce stomach-related side effects for some people.

5) Is Namenda safe for people with kidney problems?

Because memantine is cleared through the kidneys, people with reduced kidney function may need dose adjustments and closer monitoring. Tell your healthcare professional about any kidney disease or recent blood test results.

6) Can Namenda be taken with other Alzheimer’s medicines?

Often, memantine may be used alongside other treatments such as cholinesterase inhibitors, but this should be determined by your clinician based on your stage of disease and tolerability.

7) What are the most common early side effects?

Common effects include dizziness, headache, constipation, tiredness, and sometimes temporary worsening of confusion or agitation. Dose titration often helps reduce side effects.

8) What should I do if I miss a dose?

Take it when you remember if it’s close to your scheduled time. If it’s near the next dose, skip the missed one. Do not take a double dose.

9) Can I drive or operate machinery?

Namenda may cause dizziness or tiredness in some people. If you feel unsteady or unusually sleepy, avoid driving or dangerous activities and speak to your clinician or pharmacist.

10) Are there non-drug approaches that help alongside Namenda?

Yes. Structured daily routines, hearing/vision support, hydration, pain management, cognitive activities suited to ability, and caregiver education can all improve comfort and functioning. These strategies often complement medication treatment.

Summary

Namenda (memantine) is used in the management of moderate to severe Alzheimer’s disease in the UK. It works by regulating NMDA receptor signalling and may help with symptoms and day-to-day function over time. Memantine is typically introduced gradually, with dosing tailored to the individual—especially considering kidney function. While side effects can occur, many are manageable with correct titration, routine use, and prompt discussion of concerns with a healthcare professional.

If you have questions about whether Namenda is suitable for you, or how to take it safely with your existing medicines and conditions, speak to a pharmacist or healthcare professional.